Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Articolo
Data di Pubblicazione:
2021
Citazione:
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials / Cotter, Gad; Davison, Beth A; Edwards, Christopher; Senger, Stefanie; Teerlink, John R; Zannad, Faiez; Nielsen, Olav Wendelboe; Metra, Marco; Mebazaa, Alexandre; Chioncel, Ovidiu; Greenberg, Barry H; Maggioni, Aldo P; Ertl, Georg; Sato, Naoki; Cohen-Solal, Alain. - In: AMERICAN HEART JOURNAL. - ISSN 1097-6744. - 240:(2021), pp. 73-80. [10.1016/j.ahj.2021.06.001]
Abstract:
In international trials, glucagon-like protein-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2Is) were effective in improving cardiovascular (CV) outcomes.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Cardiovascular Diseases; Diabetes Mellitus; Type 2; Diabetic Nephropathies; Glucagon-Like Peptide-1 Receptor; Heart Failure; Humans; Hypoglycemic Agents; Regression Analysis; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome
Elenco autori:
Cotter, Gad; Davison, Beth A; Edwards, Christopher; Senger, Stefanie; Teerlink, John R; Zannad, Faiez; Nielsen, Olav Wendelboe; Metra, Marco; Mebazaa, Alexandre; Chioncel, Ovidiu; Greenberg, Barry H; Maggioni, Aldo P; Ertl, Georg; Sato, Naoki; Cohen-Solal, Alain
Link alla scheda completa:
Pubblicato in: